1. P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. (23rd June 2022) Authors: Lasica, M.; Spencer, A.; Campbell, P.; Wallington-Gates, C.; Wong Doo, N.; Janowski, W.; McCaughan, G.; Puliyayil, A.; Yuen, F.; Le, K.; Reynolds, J.; Quach, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗